As previously reported, BofA upgraded Synopsys (SNPS) to Buy from Neutral with a price target of $560, up from $500, arguing that the company’s “decent” FY26 guidance derisks China and Intel (INTC) sales and “clears the decks” for “attractive stock catch-up potential” and EPS beats for the next year. The firm raised its FY26 and FY27 EPS estimates following the quarterly report and guidance, the analyst noted.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNPS:
- Synopsys upgraded to Buy from Neutral at BofA
- Synopsys price target lowered to $602 from $630 at Piper Sandler
- Synopsys price target raised to $500 from $445 at Wells Fargo
- Synopsys: Strong Profitability Prospects and Raised Price Target Amid Market Challenges
- Synopsys price target raised to $600 from $575 at KeyBanc